Garuda Therapeutics, Pager, Alpha Medical
Chapter Raises $17M in Series A Funding
Chapter, a New York-based Medicare Advisor, raised $17M in Series A funding.
The round was led by Narya Capital with participation from Susa Ventures, Maverick Ventures, XYZ Venture Capital, Core Innovation Capital and Health2047 Capital Partners. Peter Thiel joined Chapter’s board of directors.
The company intends to use the funds to accelerate its product development efforts, expand its team of engineers and licensed advisors, and further invest in supporting its members.
Founded by Cobi Blumenfeld-Gantz, Corey Metzman, and Vivek Ramaswamy, Chapter provides a personalized end-to-end guidance to Americans navigating Medicare. The company has built and maintains a proprietary technology platform used by its advisors to search every Medicare plan nationwide, including Medicare Advantage, Medicare Supplements, and standalone Part D prescription plans. The advisory team earns identical compensation irrespective of the selected plan or carrier, ensuring that each Chapter member receives recommendations tailored solely for their needs.
Chapter Raises $17M in Series A Funding - FinSMEs
Chapter, a New York-based Medicare Advisor, raised $17M in Series A funding.
Fittr Raises $11.5M In Series A Funding
Fittr, a Pune, India-based health and fitness community platform, raised $11.5M in a Series A funding round.
The round was co-led by Dream Capital, the Corporate Venture Capital and M&A arm of Dream Sports and Elysian Park Ventures, the private investment arm of the LA Dodgers ownership group. Existing investor Sequoia Capital’s India Surge also participated in the funding round.
The new capital will enable the company to accelerate its growth & expansion into new markets, including North America, the UK and Singapore, which currently accounts for 30% of the company’s overall revenue, while continuing to educate the Indian population around health & fitness.
Led by Jitendra Chouksey, CEO and Founder, Fittr began as a small WhatsApp group and has grown into an engaged and informative fitness community offering physical, mental and emotional well-being solutions built around awarness and education. It is available on Android and iOS.
https://www.finsmes.com/2021/09/fittr-raises-11-5m-in-series-a-funding.html
Aglaia Therapeutics Raises €4M in Seed Funding
Aglaia Therapeutics, a Villejuif, France-based biotechnology startup developing promising new therapies that can overcome resistance to current targeted therapies in cancer patients, closed a €4M ($4.7M) seed funding round.
The round was led by Advent France Biotechnology (AFB) with participation from Crédit Mutuel Innovation and Pierre Fabre.
The proceeds of the funding will be used to prepare the preclinical development program required to identify the first candidate. Aglaia Tx aims to develop promising new oncology therapies with the goal of delivering drugs that can restore sensitivity to current targeted therapies in cancer patients that became resistant to these treatments. The company established a pipeline of small molecules in oncology targeting the initiation of mRNA translation.
https://www.finsmes.com/2021/09/aglaia-therapeutics-raises-e4m-in-seed-funding.html
WebDoctor Raises $3.54M in Funding at $56.6M Valuation
WebDoctor, a Dublin, Ireland-based health technology platform, raised $3.54m in funding.
VentureWave Capital, the venture private equity firm that focuses on entrepreneurial companies with high impact potential, made the investment, which gives a valuation of $56.6m to the business. VentureWave Capital Chairman and Managing Partner, Alan Foy, will join WebDoctor’s board of directors.
The company intends to use the funds to accelerate international growth and expansion and the scaling of the sales, marketing, product and technology teams.
Led by newly appointed CEO David Crimmins, WebDoctor is a health technology business and telehealth platform which enables engagement and collaboration between healthcare practitioners and their patients. Today, the company enables doctors to conduct their day-to-day operations virtually and to automate their booking and payment processes.
https://www.finsmes.com/2021/09/webdoctor-raises-3-54m-in-funding-at-56-6m-valuation.html
Garuda Therapeutics Raises $72M in Series A Financing
Garuda Therapeutics, a Cambridge, Mass.-based company creating off-the-shelf, durable blood stem cell therapies, raised $72m in Series A financing.
The round was led by Aisling Capital, Northpond Ventures and Orbimed, supported by Cormorant Asset Management, Ridgeback Capital Investments, Monashee Investment Management, Sectoral Asset Management, National Resilience, Inc. (Resilience), Mass General Brigham Ventures, among others.
Founded by Dhvanit Shah, Ph.D., who previously served as Principal Faculty of Harvard Stem Cell Institute, Associate Member of the Broad Institute of MIT and Harvard, and Principal Investigator at Brigham and Women’s Hospital, David Scadden, M.D. and Sean Morrison, Ph.D., Garuda is developing an off-the-shelf hematopoietic stem cell platform that will eliminate dependency on donor or patient cells. The platform for generating off-the-shelf, self-renewing blood stem cells is designed to provide patients with rapid and broad access to consistent, durable, HLA-matched transgene-free blood stem cell therapies.
Garuda Therapeutics Raises $72M in Series A Financing
Garuda Therapeutics, a Cambridge, Mass.-based company creating off-the-shelf, durable blood stem cell therapies, raised $72m in Series A financing
Intenseye Raises $25M in Series A Funding
Intenseye, a New York and Istanbul, Turkey-based health and safety (EHS) company, raised $25M in Series A funding.
The round was led by Insight Partners with significant participation Point Nine and Air Street Capital, as well as Alex Dalyac, CEO of insurance computer vision company Tractable.
The company intends to use the funds to further expand its go-to-market strategy and build on its existing customer base of international manufacturers.
Led by Sercan Esen, CEO and Serhat Cillidag, CTO, Intenseye provides an AI-powered employee health and safety (EHS) software platform that allows large enterprises to scale employee health and safety across their facility footprints to mitigate workplace accidents and fatalities. It integrates 24/7 with existing camera video feeds from facilities and anonymously identifies health and safety violations in real-time, enabling rapid remediation and safer work environments.
Intenseye Raises $25M in Series A Funding - FinSMEs
Intenseye, a New York and Istanbul-based health and safety (EHS) company, raised $25M in Series A funding.
Elligo Health Research Raises $135M in Series E Financing
Elligo Health Research, an Austin, TX-based tech powered, healthcare-enabling research organization, raised $135m in Series E financing.
Morgan Stanley Expansion Capital and Ally Bridge Group, completed the investment in Elligo with participation from Norwest Venture Partners and all major existing investors.
The company intends to use the funds to acquire ClinEdge and invest further in the technology & data platform.
Led by CEO John Potthoff, Elligo is a healthcare-enabling research organization powered by its IntElligo Research Stack technology, which uses electronic health records and the trusted patient and physician relationship to ensure all patients have access to clinical research as a care option. It directly engages physicians and patients and accelerates the development of new pharmaceutical, biotechnology, and medical device and diagnostic products.
Elligo Health Research Raises $135M in Series E Financing
Elligo Health Research, an Austin, TX-based tech powered, healthcare-enabling research organization, raised $135m in Series E financing
Pager Secures $70M in Funding
Pager, a NYC-based virtual care navigation and collaboration platform, raised $70m in Series C equity and debt financing round.
The Series-C round was led by Susquehanna Private Equity Investments, an affiliate of Susquehanna International Group LLLP (SIG), and included new and existing financial and strategic investors, including an affiliate of Horizon Healthcare Services, Inc., New Jersey’s largest health insurer. Debt financing was provided by Silicon Valley Bank.
The company intends to use the funds to scale capacity to meet record pipeline demand, accelerate innovation of the platform, and support the geographic expansion to new markets in the United States, Latin America and worldwide.
Led by Walter Jin, CEO and Chairman, Pager is a virtual care collaboration platform that provides whole person healthcare in a connected care experience. Through a combination of hi-tech AI automation and concierge services, the company offers an integrated, full-service experience including triage, telemedicine, e-prescriptions, appointment scheduling, after-care follow-up, care advocacy, and customer service. Its omni-channel communications platform connects the healthcare ecosystem by aggregating a care team of nurses, doctors, pharmacists, coordinators, advocates, and more in one place. Pager partners with payers, providers and employers representing more than 15 million people across the United States and Latin America.
Pager Secures $70M in Funding
Pager, a NYC-based virtual care navigation and collaboration platform, raised $70m in Series C equity and debt financing round
858 Therapeutics Raises $60M in Series A Funding
858 Therapeutics, a San Diego CA-based biotechnology and drug discovery company, raised $60M in Series A funding.
The round was led by Versant Ventures, with participation from NEA, Cormorant Asset Management and Logos Capital.
The company intends to use the funds to enter the clinic with its lead candidates that have potential to treat cancers that are resistant to current therapies and to expand its team to about 40 people within the next 18 months.
Led by CEO Jeffrey Stafford, 858 Therapeutics is developing a portfolio of small molecules directed against novel therapeutic targets in oncology, including proteins that regulate RNA and the innate immune response. The company has built a platform to assess the impact of RNA-modifying proteins on disease biology and has generated a pipeline of small molecules against priority targets.
858’s founding team includes CEO Jeffrey Stafford, Ph.D., CSO James Veal, Ph.D., and VP of Biology Gretchen Bain, Ph.D. They previously held leadership roles at three other San Diego-based discovery companies co-founded by Versant including Jecure Therapeutics, Quanticel Pharmaceuticals and Amira Pharmaceuticals.
858 Therapeutics Raises $60M in Series A Funding - FinSMEs
858 Therapeutics, a San Diego CA-based biotechnology and drug discovery company, raised $60M in Series A funding
Centivo Raises $51M in Funding
Centivo, a Buffalo NY-based health plan company serving self-funded employers, raised $51M in funding.
The round was led by B Capital Group and Maverick with participation from Bain Capital Ventures, Company Ventures, Define Ventures, F-Prime Capital, HarbourVest Partners, Ingleside Investors and Nassau Street Ventures.
The company intends to use the funds for growth and expansion and development of products and services such as a fully integrated virtual primary care-centered health plan, which was recently launched in Florida.
Led by Ashok Subramanian, CEO, Centivo provides an health plan anchored around providers of value-based care, now serving employer clients ranging in size from 100 employees to Fortune 500 companies. By the end of 2022, the company’s health plan will be available in half of the top 20 metropolitan areas in the country. The firm also recently developed a new strategic distribution arrangement with the Business Health Care Group (BHCG) in eastern Wisconsin.
https://www.finsmes.com/2021/09/centivo-raises-51m-in-funding.html
Cytrellis Biosystems Closes $50M Series C Financing
Cytrellis Biosystems, a Woburn, Mass.-based medical technology company dedicated to the development and commercialization of aesthetic devices which emphasize safety, efficacy, and improved quality of life for patients, closed a $50m Series C funding round.
The round was led by D1 Capital Partners with participation from an additional new investor, Sands Capital, as well as existing institutional investors ARCH Venture Partners and PFM Health Sciences.
The company intends to use the funds to develop its commercial infrastructure as well as support additional clinical research, product development, and manufacturing.
Led by Karen Cronholm, President and CEO, Cytrellis Biosystems has developed a novel class of aesthetic devices designed to remove sagging skin associated with aging without surgery or scarring, enabling aesthetic practitioners the ability to improve age related changes in skin and restore youthful beauty. The ellacor™ System with Micro-Coring™ Technology is indicated for use by medical professionals for the treatment of moderate to severe wrinkles in the mid to lower face in adults aged 22 years or older with Fitzpatrick skin types I-IV. Ellacor’s recent FDA clearance* provides a pathway to an initial commercial rollout, which Cytrellis intends to execute with a small group of key physicians. The company anticipates a full national rollout in 2022.
Cytrellis Biosystems Closes $50M Series C Financing - FinSMEs
Cytrellis, a Woburn, Mass.-based medical technology company dedicated to the development and commercialization of aesthetic devices which emphasize safety, efficacy, and improved quality of life for patients, closed a $50m Series C funding round
eVisit Raises $45M in Series B Funding
eVisit, a Mesa, Ariz.-based SaaS telehealth Company, raised $45M in Series B funding.
The round was led by the Growth Equity business within Goldman Sachs Asset Management, with participation from Texas Health Resources, Tom Burton and Steve Barlow (Co-founders of Health Catalyst), and existing insiders.
The company intends to use the funds to scale up its sales and marketing efforts and further invest in its technology platform and capabilities.
Led by Bret Larsen, CEO, eVisit provides an HIPAA-compliant telehealth platform that powers key Virtual Care workflows for large-scale health systems, hospitals and Integrated Delivery Networks (IDNs), creating a digital extension of existing brick-and-mortar care delivery networks.
https://www.finsmes.com/2021/09/evisit-raises-45m-in-series-b-funding.html
Nocd Raises $33M in Series B Financing
NOCD, a Chicago, IL-based provider of obsessive compulsive-disorder (OCD) treatment, closed a $33m Series B funding round.
The round was led by F-Prime Capital, with participation from Eight Roads Ventures, and Kaiser Permanente Ventures participating along with existing investors including 7wireVentures, Health Enterprise Partners (HEP), and Chicago Ventures.
The company intends to use the funds to expand its community, reach people earlier in their treatment journey, and offer additional services to assist with their long-term health.
Led by Stephen Smith, Chief Executive Officer and founder, NOCD is a telehealth provider for the treatment of obsessive- compulsive disorder (OCD) and a Community-Driven Therapy company which helps people reclaim their lives with clinically proven OCD treatment by removing barriers to care, and by reducing the stigma associated with OCD. Inside the NOCD platform, members can quickly access a national network of licensed therapists that specialize in Exposure and Response Prevention (ERP), the “gold standard” for OCD treatment.
Nocd Raises $33M in Series B Financing
NOCD, a Chicago, IL-based provider of obsessive compulsive-disorder (OCD) treatment, closed a $33m Series B funding round
Alpha Medical Raises $24M in Series B Funding
Alpha Medical, a Palo Alto, Calif.-based women’s virtual primary care company, raised $24m in Series B funding.
Investors included SpringRock Ventures, Margo Georgiadis, Outcomes Collective Growth Capital, FMZ Ventures, Samsung Next, Chamaeleon, AV8 Ventures, and GSR Ventures.
The company intends to use the funds to continue to expand operations and its business reach.
Led by Gloria Lau, Co-founder & CEO, Alpha Medical leverages a telemedicine platform to cover women’s healthcare needs virtually, from birth control to menopause, from urgent care to chronic disease. Each patient gets a dedicated PCP when she signs up, and the same provider cares for primary medical needs online to ensure continuation of care. The system anticipates her needs through data-driven proactive screenings for triage, prescription management, therapy, and referrals.
https://www.finsmes.com/2021/09/alpha-medical-raises-24m-in-series-b-funding.html
Moroccan e-health startup DataPathology raises $223k funding
Moroccan e-heath startup DataPathology has raised MAD2 million (US$$223,000) to help it transform the pathological diagnosis system and improve services provided to practitioners and patients.
Founded in 2020 by Hicham El Attar and Mohammed El Khannoussi, DataPathology fights shortage and delays of diagnosis of cancer patients in rural areas, providing healthcare practitioners with a complete solution to help them deliver a quality pathological diagnosis, quickly and efficiently.
The startup is now planning to scale that solution across Morocco and Africa with the help of funding from investment company Witamax, founded by Southbridge A&I and Axxam Family Office. The MAD2 million will help it deploy to new sites, expand its team and ultimately become a key e-health player on the continent.
